US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 23.460
  • +0.390+1.69%
Close 02/23 16:00 ET
  • 23.460
  • 0.0000.00%
Post 18:14 ET
1.04BMarket Cap-16224P/E (TTM)

Silence Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)2023/09/30
(Q2)2023/06/30
(Q1)2023/03/31
(FY)2022/12/31
(Q4)2022/12/31
(Q3)2022/09/30
(Q2)2022/06/30
(Q1)2022/03/31
(FY)2021/12/31
(Q4)2021/12/31
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
48.19%-4.87M
-80.89%-14.96M
46.74%-7.66M
-767.88%-45.46M
-508.07%-13.41M
-90.87%-9.4M
-131.76%-8.27M
-18.88%-14.38M
163.16%6.81M
59.22%-2.21M
Net income from continuing operations
-14.31%-10.66M
10.51%-12.01M
-32.40%-12.67M
-3.30%-47.37M
-34.05%-15.05M
22.61%-9.33M
-5.60%-13.42M
3.02%-9.57M
-27.23%-45.86M
14.77%-11.23M
Operating gains losses
363.72%596K
368.97%312K
-26.32%84K
133.77%713K
77.21%941K
23.39%-226K
-111.87%-116K
112.56%114K
-90.95%305K
1,395.12%531K
Depreciation and amortization
9.65%125K
3.51%118K
18.58%134K
12.88%482K
113.64%141K
3.64%114K
-7.32%114K
-11.72%113K
-13.91%427K
-64.52%66K
Other non cash items
52.92%-2.04M
182.66%553K
249.71%524K
-3,128.57%-1.27M
11,422.22%4.08M
-1,765.95%-4.33M
-205.48%-669K
-166.16%-350K
100.90%42K
99.05%-36K
Change In working capital
86.16%3.67M
-350.83%-6.93M
6.24%-7.27M
-121.27%-8.26M
-179.18%-5.24M
261.17%1.97M
-92.14%2.76M
-124.03%-7.76M
108.22%38.85M
24.02%6.62M
-Change in receivables
273.08%10.34M
-3,296.33%-11.11M
64.11%-805K
-103.95%-1.09M
29.40%-1.29M
532.65%2.77M
-100.98%-327K
48.99%-2.24M
193.79%27.48M
-170.03%-1.82M
-Change in payables and accrued expense
-96.89%94K
-132.03%-1.23M
113.52%419K
-39.83%1.45M
-269.29%-2.3M
121.07%3.02M
253.14%3.83M
-120.26%-3.1M
84.57%2.41M
-38.56%1.36M
-Change in other current assets
-124.63%-4.55M
176.41%1.61M
298.25%1.36M
-818.54%-4.23M
122.66%598K
-2,302.17%-2.03M
-187.81%-2.11M
-193.84%-686K
115.76%588K
94.71%-2.64M
-Change in other working capital
-23.12%-2.21M
176.31%3.79M
-377.20%-8.25M
-152.56%-4.4M
-123.13%-2.25M
9.43%-1.8M
240.00%1.37M
-207.26%-1.73M
-83.39%8.37M
403.11%9.72M
Cash from discontinued investing activities
Operating cash flow
48.19%-4.87M
-80.89%-14.96M
46.74%-7.66M
-767.88%-45.46M
-508.07%-13.41M
-90.87%-9.4M
-131.76%-8.27M
-18.88%-14.38M
163.16%6.81M
59.22%-2.21M
Investing cash flow
Cash flow from continuing investing activities
49,214.29%20.63M
-13,351.43%-4.71M
350.98%128K
-290.66%-16.54M
-468.69%-16.41M
-100.90%-42K
91.97%-35K
-292.31%-51K
-9.79%8.68M
-77.71%4.45M
Net PPE purchase and sale
57.45%-20K
103.33%3K
---27K
89.32%-140K
99.43%-3K
85.80%-47K
79.50%-90K
--0
-158.07%-1.31M
-479.12%-527K
Net intangibles purchase and sale
----
----
---6K
-1,204.35%-300K
----
----
----
--0
-666.67%-23K
----
Net investment purchase and sale
--20.1M
-229,150.00%-4.59M
--0
-261.25%-16.13M
-422.50%-16.13M
--0
---2K
--2K
0.00%10M
-75.03%5M
Cash from discontinued investing activities
Investing cash flow
49,214.29%20.63M
-13,351.43%-4.71M
350.98%128K
-290.66%-16.54M
-468.69%-16.41M
-100.90%-42K
91.97%-35K
-292.31%-51K
-9.79%8.68M
-77.71%4.45M
Financing cash flow
Cash flow from continuing financing activities
-72.06%12.03M
29,045.45%3.18M
140.43%19K
40.17%43.05M
44K
10,032.47%43.06M
82.26%-11K
-100.15%-47K
99.06%30.71M
0
Net issuance payments of debt
-226.67%-49K
32.00%-34K
-2.13%-48K
9.95%-190K
-7,700.00%-78K
-103.69%-15K
90.04%-50K
58.77%-47K
47.51%-211K
99.23%-1K
Net common stock issuance
-71.96%12.08M
8,151.28%3.22M
--67K
39.83%43.24M
12,100.00%122K
226,626.32%43.08M
-91.14%39K
--0
95.34%30.92M
-95.83%1K
Cash from discontinued financing activities
Financing cash flow
-72.06%12.03M
29,045.45%3.18M
140.43%19K
40.17%43.05M
--44K
10,032.47%43.06M
82.26%-11K
-100.15%-47K
99.06%30.71M
--0
Net cash flow
Beginning cash position
-42.36%29.72M
-21.19%46.73M
-25.46%54.82M
167.90%73.54M
25.95%90.02M
-27.62%51.57M
29.67%59.3M
167.90%73.54M
103.10%27.45M
413.61%71.47M
Current changes in cash
-17.34%27.79M
-98.22%-16.48M
48.12%-7.51M
-141.02%-18.95M
-1,425.23%-29.78M
19,559.06%33.62M
-132.56%-8.31M
-179.34%-14.47M
223.71%46.19M
-84.46%2.25M
Effect of exchange rate changes
-73.03%1.3M
-190.92%-531K
-348.28%-576K
317.14%228K
-2,929.61%-5.42M
7,958.33%4.84M
2,880.95%584K
562.86%232K
68.75%-105K
80.61%-179K
End cash Position
-34.67%58.81M
-42.36%29.72M
-21.19%46.73M
-25.46%54.82M
-25.46%54.82M
25.95%90.02M
-27.62%51.57M
29.67%59.3M
167.90%73.54M
167.90%73.54M
Free cash flow
48.24%-4.89M
-78.83%-14.95M
46.52%-7.69M
-938.74%-45.9M
-397.68%-13.71M
-79.75%-9.45M
-132.66%-8.36M
-18.74%-14.38M
148.47%5.47M
49.95%-2.76M
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)2023/09/30(Q2)2023/06/30(Q1)2023/03/31(FY)2022/12/31(Q4)2022/12/31(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 48.19%-4.87M-80.89%-14.96M46.74%-7.66M-767.88%-45.46M-508.07%-13.41M-90.87%-9.4M-131.76%-8.27M-18.88%-14.38M163.16%6.81M59.22%-2.21M
Net income from continuing operations -14.31%-10.66M10.51%-12.01M-32.40%-12.67M-3.30%-47.37M-34.05%-15.05M22.61%-9.33M-5.60%-13.42M3.02%-9.57M-27.23%-45.86M14.77%-11.23M
Operating gains losses 363.72%596K368.97%312K-26.32%84K133.77%713K77.21%941K23.39%-226K-111.87%-116K112.56%114K-90.95%305K1,395.12%531K
Depreciation and amortization 9.65%125K3.51%118K18.58%134K12.88%482K113.64%141K3.64%114K-7.32%114K-11.72%113K-13.91%427K-64.52%66K
Other non cash items 52.92%-2.04M182.66%553K249.71%524K-3,128.57%-1.27M11,422.22%4.08M-1,765.95%-4.33M-205.48%-669K-166.16%-350K100.90%42K99.05%-36K
Change In working capital 86.16%3.67M-350.83%-6.93M6.24%-7.27M-121.27%-8.26M-179.18%-5.24M261.17%1.97M-92.14%2.76M-124.03%-7.76M108.22%38.85M24.02%6.62M
-Change in receivables 273.08%10.34M-3,296.33%-11.11M64.11%-805K-103.95%-1.09M29.40%-1.29M532.65%2.77M-100.98%-327K48.99%-2.24M193.79%27.48M-170.03%-1.82M
-Change in payables and accrued expense -96.89%94K-132.03%-1.23M113.52%419K-39.83%1.45M-269.29%-2.3M121.07%3.02M253.14%3.83M-120.26%-3.1M84.57%2.41M-38.56%1.36M
-Change in other current assets -124.63%-4.55M176.41%1.61M298.25%1.36M-818.54%-4.23M122.66%598K-2,302.17%-2.03M-187.81%-2.11M-193.84%-686K115.76%588K94.71%-2.64M
-Change in other working capital -23.12%-2.21M176.31%3.79M-377.20%-8.25M-152.56%-4.4M-123.13%-2.25M9.43%-1.8M240.00%1.37M-207.26%-1.73M-83.39%8.37M403.11%9.72M
Cash from discontinued investing activities
Operating cash flow 48.19%-4.87M-80.89%-14.96M46.74%-7.66M-767.88%-45.46M-508.07%-13.41M-90.87%-9.4M-131.76%-8.27M-18.88%-14.38M163.16%6.81M59.22%-2.21M
Investing cash flow
Cash flow from continuing investing activities 49,214.29%20.63M-13,351.43%-4.71M350.98%128K-290.66%-16.54M-468.69%-16.41M-100.90%-42K91.97%-35K-292.31%-51K-9.79%8.68M-77.71%4.45M
Net PPE purchase and sale 57.45%-20K103.33%3K---27K89.32%-140K99.43%-3K85.80%-47K79.50%-90K--0-158.07%-1.31M-479.12%-527K
Net intangibles purchase and sale -----------6K-1,204.35%-300K--------------0-666.67%-23K----
Net investment purchase and sale --20.1M-229,150.00%-4.59M--0-261.25%-16.13M-422.50%-16.13M--0---2K--2K0.00%10M-75.03%5M
Cash from discontinued investing activities
Investing cash flow 49,214.29%20.63M-13,351.43%-4.71M350.98%128K-290.66%-16.54M-468.69%-16.41M-100.90%-42K91.97%-35K-292.31%-51K-9.79%8.68M-77.71%4.45M
Financing cash flow
Cash flow from continuing financing activities -72.06%12.03M29,045.45%3.18M140.43%19K40.17%43.05M44K10,032.47%43.06M82.26%-11K-100.15%-47K99.06%30.71M0
Net issuance payments of debt -226.67%-49K32.00%-34K-2.13%-48K9.95%-190K-7,700.00%-78K-103.69%-15K90.04%-50K58.77%-47K47.51%-211K99.23%-1K
Net common stock issuance -71.96%12.08M8,151.28%3.22M--67K39.83%43.24M12,100.00%122K226,626.32%43.08M-91.14%39K--095.34%30.92M-95.83%1K
Cash from discontinued financing activities
Financing cash flow -72.06%12.03M29,045.45%3.18M140.43%19K40.17%43.05M--44K10,032.47%43.06M82.26%-11K-100.15%-47K99.06%30.71M--0
Net cash flow
Beginning cash position -42.36%29.72M-21.19%46.73M-25.46%54.82M167.90%73.54M25.95%90.02M-27.62%51.57M29.67%59.3M167.90%73.54M103.10%27.45M413.61%71.47M
Current changes in cash -17.34%27.79M-98.22%-16.48M48.12%-7.51M-141.02%-18.95M-1,425.23%-29.78M19,559.06%33.62M-132.56%-8.31M-179.34%-14.47M223.71%46.19M-84.46%2.25M
Effect of exchange rate changes -73.03%1.3M-190.92%-531K-348.28%-576K317.14%228K-2,929.61%-5.42M7,958.33%4.84M2,880.95%584K562.86%232K68.75%-105K80.61%-179K
End cash Position -34.67%58.81M-42.36%29.72M-21.19%46.73M-25.46%54.82M-25.46%54.82M25.95%90.02M-27.62%51.57M29.67%59.3M167.90%73.54M167.90%73.54M
Free cash flow 48.24%-4.89M-78.83%-14.95M46.52%-7.69M-938.74%-45.9M-397.68%-13.71M-79.75%-9.45M-132.66%-8.36M-18.74%-14.38M148.47%5.47M49.95%-2.76M
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg